Home
Search
BIO International Convention   |   June 3-6, 2024

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Karthik Venkatakrishnan, PhD
VICE PRESIDENT, GLOBAL HEAD OF QUANTITATIVE PHARMACOLOGY, EMD SERONO
Dose Optimization in Oncology: How Do We Tackle the Tricky Topic of Combinations?
Dominique Verhelle, MBA,PhD
CO-FOUNDER, CHIEF EXECUTIVE OFFICER AND CHIEF SCIENTIFIC OFFICER, NEXTRNA
Don't Be Afraid of the Dark Genome: New Therapies from Regulatory Non-Coding RNA
Boston, Massachusetts, United States
Patrick Verhoest, PhD
VP, MEDICINE DESIGN, PFIZER
The Art and Science of Applying AI in the Race to Protect Global Public Health
Annemiek Verkamman, ACA
THE NETHERLANDS: EUROPE'S CONNECTED LIFE SCIENCES & HEALTH METROPOLIS, HEALTH~HOLLAND
Health~Holland
The Hague, Netherlands
Laura Veroneau
MANAGING DIRECTOR, OPTUM VENTURES
Investors' Perspectives: Digital Health Trends and Investment Thesis in 2023 and Beyond
Patrice Verpillat
HEAD OF THE REAL WORLD EVIDENCE (RWE) WORKSTREAM, EUROPEAN MEDICINES AGENCY
Real-World Evidence in Regulatory Decision-Making: Enabling its Use Through International CReal-World Evidence in Regulatory Decision-Making: Enabling its Use Through International Collaboration
Christopher Viehbacher
PRESIDENT AND CHIEF EXECUTIVE OFFICER, BIOGEN
Fireside Chat with Christopher Viehbacher, President and Chief Executive Officer, Biogen
Jo Viney, Not Applicable
FOUNDER, PRESIDENT AND CEO, SEISMIC THERAPEUTIC
Crafting a Compelling Pitch to Seasoned Investors & Partners When Your Platform Offers a New Technology Approach in an Existing Field
Investing in the Value of DEI for Your Company and Community
Perspectives on Target Selection: How Companies Approach a Critical Decision
Cambridge, Massachusetts, United States
Shelia Violette, PhD
CSO, PRESIDENT OF RESEARCH, Q32 BIO INC.
Perspectives on Target Selection: How Companies Approach a Critical Decision
Cambridge, Massachusetts, United States
Gina Vitale
EDITOR, C&EN
From Serendipity to Rational Design, Redefining the Rules of Molecular Glue Discovery